DETECTION OF CRYPTOSPORIDIUM-INDUCED INTESTINAL TISSUE ALTERATIONS IN DEXAMETHASONE TREATED & UN-TREATED MICE

POTENTIAL IMMUNOMODULATORY EFFECT OF SINGLE AND COMBINED THERAPIES AGAINST CRYPTOSPORIDIUM INFECTION IN IMMUNOSUPPRESSED MOUSE MODEL

Control of the Waterborne Cryptosporidiosis: Evaluation of the Protective Role of Cryptosporidium parvum Oocysts Antigen in Infected Immunocompetent and Immunosuppressed Mice

ROLE OF APOPTOSIS IN EXPERIMENTAL CRYPTOSPORIDIUM PARVUM INFECTED ALBINO MICE

IMPACT OF IMMUNE SUPPRESSION ON HISTOPATHOLOGICAL AND IMMUNOLOGICAL PARAMETERS OF MICE EXPERIMENTALLY INFECTED WITH GIARDIA LAMBLIA

Effects of Echinacea Purpurea on Cryptosporidiosis in Immunosuppressed Experimentally Infected Mice

Prolonged Cryptosporidium Parvum Infection Can Be a Risk Factor for Intestinal Malignancy Even In Immunocompetent Host

EFFECT OF <i>CRYPTOSPORIDIUM PARVUM</i> INFECTION ON DNA DAMAGE AND CYTOKINES GENE EXPRESSION IN BLOOD OF IMMUNOCOMPROMISED MICE

EFFECT OF SOME MEDICINAL HERBS VERSUS NITAZOXANIDE ON CRYPTOSPORIDIUM PARVUM INFECTED IMMUNOSUPPRESSED MICE

PARASITOLOGICAL ASSESSMENT OF DIFFERENT CONCENTRATIONS OF PIPERAZINE CITRATE AGAINST CRYPTOSPORIDIOSIS INFECTION IN BOTH IMMUNOCOMPETENT AND IMMUNOCOMPROMISED MICE